Skip to main content

Anders Jack's Form 4 filing

Revolution Medicines, Inc.RVMD · filed Sep 18, 2026

Accession no.
0001800668-26-000007
Filed
Sep 18, 2026, 6:00 PM ET
Trade date
Sep 16, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions. Open-market sales total $807.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Anders JackCIK 0001800668Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 16, 2026Common StockSSaleDisposed−61$195.00−$11,895123,208Direct
Sep 16, 2026Common StockSSaleDisposed−3,992$199.30−$795,618.37119,216Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)